Industry Reports
Bayer interim report for the first quarter shows a successful start of 2016
Bayer interim report for the first quarter shows a successful start of 2016Substantial sales growth at Pharmaceuticals / Earnings expand in all segments /...
News
Mallinckrodt to Present at UBS Global Healthcare Conference
Mallinckrodt Pharmaceuticals a leading global specialty biopharmaceutical company, will present on Tuesday, May 24, 2016, at the UBS Global Healthcare Conference at the Grand...
News
AstraZeneca enters into US licensing agreement with Ironwood Pharmaceuticals for lesinurad
AstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic® (lesinurad). Zurampic was approved...
Industry Reports
Baxter Provides Updated Financial Outlook for 2016
Positive Sales Mix and Disciplined Expense Management Contribute to Strong First Quarter Performance; Adjusted Earnings Per Share were $0.36; First-quarter GAAP Earnings Per Share...
Press Releases
Allergan plc to add 322,000 square feet of manufacturing space in its Texas facility, costing $200 million
Expansion to add more than 100 full time jobs to local Waco and Central Texas economies -- Will add 322,000 square feet of...
Research Insight
OFIRMEV (Acetaminophen) Injection Health Economic Data Presented and Specially Recognized at Annual Congress of Enhanced Recovery and Perioperative Medicine
Mallinckrodt plc a leading global specialty biopharmaceutical company announced the results from a retrospective analysis of health economic data on the use of OFIRMEV...
Research Insight
AbbVie, CytomX to co-develop for Probody Drug Conjugates
AbbVie and CytomX Therapeutics, Inc announced that they have entered into a collaboration to co-develop and co-commercialize Probody™ Drug Conjugates against CD71, also...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read